Fulgent Genetics Inc reports results for the quarter ended in June - Earnings Summary

Fulgent Genetics

04/08/2023 14:33

* Fulgent Genetics Inc  FLGT.OQ  reported a quarterly
adjusted
loss of 8 cents​​ per share for the quarter ended in June. The
mean expectation of three analysts for the quarter was for a
loss of 33 cents per share.
    * Revenue fell 45.9% to $67.85 million from a year ago;
analysts
expected $62.48 million. 
    * Fulgent Genetics Inc's reported EPS for the quarter was a
loss
of 38 cents​.
    * The mean earnings estimate of analysts had fallen by
about 3.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Fulgent Genetics Inc shares had risen by 8.2% this
quarter and
gained 34.6% so far this year.
    * The company reported a quarterly loss of $11.23 million.
    * Wall Street's median 12-month price target for Fulgent
Genetics
Inc is $45.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 4 at 01:33 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.33          -0.08          Beat
 Mar. 31 2023      -0.43          -0.22          Beat
 Dec. 31 2022      -0.56          -0.48          Beat
 Sep. 30 2022      0.05           0.32           Beat